Contact Us |

Search 

עברית  

    logoemp

 

slogN

Investors3-33

 
 
 

Presentations

 PLX-PAD 1301-01 Summary of Efficacy FINALPLX-PAD01

 

 

Pluristem Therapeutics Inc.'s Corporate Presentation

September 2014

 

 


 

pta01

 

Pluristem’s Regenerative Medicine Day 

Tobias Winkler, M.D., Ph.D., Charité, University Medicine 


 psti v10 01

Pluristem’s Regenerative Medicine Day

Jason Kolbert, Maxim Group


 Zavoico TelAviv01

 

Pluristem’s Regenerative Medicine Day

George B. Zavoico, H.C. Wainwright


 

 

 

Pluristem Therapeutics, Inc.
Live Stock Ticker

NASDAQ  PLTR

 
Share Button
 

The content, text, graphics, data, and services offered herein (the "Content") are provided solely to educate users of this web site on Pluristem and the goods and/or services it provides.  Nothing in the Content should be considered, or used as a substitute for, medical advice, diagnosis or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.  Reliance on the Content or any portion thereof, or other visitors to the web site, is solely at your own risk.